Original Article
Journal of Cerebral Blood Flow & Metabolism (2004) 24, 291–297; doi:10.1097/01.WCB.0000110540.96047.C7
Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm
The present study was funded by the Departments of Neurologic Surgery and Neurology, Mayo Clinic and Mayo Foundation.
Vini G Khurana*, Youvraj R Sohni†, Wells I Mangrum*, Robyn L McClelland‡, Dennis J O'Kane†, Fredric B Meyer* and Irene Meissner§,¶
- *Department of Neurologic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
- †Department of Microarray Shared Resource, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
- ‡Department of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
- §Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
- ¶Mayo Stroke Center, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Correspondence: Irene Meissner, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA; E-mail: meissner.irene@mayo.edu.
Received 21 August 2003; Revised 5 October 2003; Accepted 17 November 2003.
Abstract
Rupture of an intracranial aneurysm (subarachnoid hemorrhage) is a potentially devastating condition frequently complicated by delayed cerebral ischemia from sustained contraction of intracranial arteries (cerebral vasospasm). There is mounting evidence linking the formation of intracranial aneurysms and the pathogenesis of post-subarachnoid hemorrhage vasospasm to aberrant bioavailability and action of the vasodilator molecule nitric oxide generated by isoforms of nitric oxide synthase. In humans, the gene encoding the endothelial isoform of nitric oxide synthase (eNOS) is known to be polymorphic, with certain polymorphisms associated with increased cardiovascular disease susceptibility. In this prospective clinical study involving 141 participants, we used gene microarray technology to demonstrate that the eNOS gene intron-4 27-base pair variable number tandem repeat polymorphism (eNOS 27 VNTR) predicts susceptibility to intracranial aneurysm rupture, while the eNOS gene promoter T-786C single nucleotide polymorphism (eNOS T-786C SNP) predicts susceptibility to post-subarachnoid hemorrhage vasospasm. We believe that genetic information such as this, which can be obtained expeditiously at the time of diagnosis, may be used as a helpful adjunct to other clinical information aimed at predicting and favorably modifying the clinical course of persons with intracranial aneurysms.
Keywords:
Nitric oxide synthase, Genetic polymorphism, Cerebral vasospasm, Intracranial aneurysm, Subarachnoid hemorrhage
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
New detachable coils for treating cerebral aneurysmsNature Medicine News and Views (01 Feb 1996)
RESEARCH
Mutants of Puccinia graminis avenae induced by Ethyl Methane SulphonateNature Letters to Editor (05 Feb 1966)
The role of endothelial nitric oxide synthase (eNOS) genetic variants in European patients with intracranial aneurysmsJournal of Cerebral Blood Flow & Metabolism Original Article
Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Cerebral Blood Flow & Metabolism Original Article
See all 51 matches for Research
